SPY330.65-3.85 -1.15%
DIA276.52-2.38 -0.85%
IXIC10,793.28-117.00 -1.07%

Unum Therapeutics Q1 EPS $(0.200) Up From $(0.390) YoY, Sales $7.000M Up From $3.100M YoY

Unum Therapeutics (NASDAQ:UMRX) reported quarterly losses of $(0.200) per share. This is a 48.72 percent increase over losses of $(0.390) per share from the same period last year. The company reported $7.000 million in

Benzinga · 05/11/2020 21:01

Unum Therapeutics (NASDAQ:UMRX) reported quarterly losses of $(0.200) per share. This is a 48.72 percent increase over losses of $(0.390) per share from the same period last year. The company reported $7.000 million in sales this quarter. This is a 125.81 percent increase over sales of $3.100 million the same period last year.